Open Access
CC BY 4.0 · Aorta (Stamford) 2022; 10(S 01): A1-A56
DOI: 10.1055/s-0042-1750996
Presentation Abstracts

Sutureless Aortic Prosthesis, 11-Year Experience With a Technology between the Surgical and the Transcatheter Worlds

Authors

  • Emmanuel Villa

    1   Cardiac Surgery, Poliambulanza Foundation Hospital, Brescia, Italy
Weitere Informationen
Auch verfügbar auf
 
 

    Aortic valve replacement (AVR) by sutureless prostheses changed surgeon options, but there is still controversy concerning the performance of nitinol technology in open heart operations. This study reviews a large single center experience with Perceval trough 11 years of continuous use. Between 2011, when Perceval (Sorin) was commercially available in Europe, and 2022 (Perceval Livanova and now Corcym), 560 patients underwent AVR with this type of sutureless prosthesis in isolated or combined procedures. We performed a retrospective analysis of early clinical results.


     

    Die Autoren geben an, dass kein Interessenkonflikt besteht.

    Publikationsverlauf

    Artikel online veröffentlicht:
    10. Juni 2022

    © 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

    Thieme Medical Publishers, Inc.
    333 Seventh Avenue, 18th Floor, New York, NY 10001, USA